<DOC>
	<DOCNO>NCT00484718</DOCNO>
	<brief_summary>The Purpose trial evaluate use cross-over trial design osteoarthritis population . We determine inter- intra-subject variability osteoarthritis ( OA ) endpoints evaluate efficacy detect measure OA endpoint follow treatment 2 different type analgesic crossover study design .</brief_summary>
	<brief_title>Measuring Gait And Self-Reported Pain In Patients With Osteoarthritis Of The Knee Using Placebo/Oxycodone/Celecoxib .</brief_title>
	<detailed_description>Methodology study evaluate use cross design gait analysis . The study terminate mutual consent study site meeting 1 April 2009 , slow recruitment due high screen fail rate . The study stop safety reason .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<mesh_term>Oxycodone</mesh_term>
	<criteria>Subject take NSAID least 15 past 30 day index knee pain Grades 2 3 OA define Kellgren Lawrence Grading System medial tibiofemoral joint ( joint space narrow medial compartment &gt; lateral compartment assess xray ) use Altman Atlas OA7 . This must document report xray study joint take either screen within 1 year prior screen Subject meet American College Rheumatology ( ACR ) clinical classification criterion osteoarthritis knee , define follow : Knee pain least 3 follow : oAge &gt; 50 oMorning stiffness &lt; 30 minute oCrepitus active motion oBony tenderness oBony enlargement oNo palpable warmth synovium . Subject documented history allergic reaction ( hive , rash , etc . ) clinically significant intolerance celecoxib , sulfonamide , aspirin , opioids include oxycodone Significant pain outside index knee , include significant hip back pain distinguish OA pain interferes ability walk . ( Patients bilateral knee OA allow study . The index knee define painful knee Predominantly patellofemoral knee osteoarthritis index knee assess clinical examination Subject unable discontinue formulation prior analgesic acetaminophen Washout Period study , anticipate unable discontinue rescue medication 24 hour prior respective visit . ( Low dose aspirin may take cardiac prophylaxis Excessive signal knee joint laxity indicative functional ligamentous deficiency</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>